Bella Praxis S.R.L.
Paşcani 705200
0 studies enrolling now · 4 studies all time
What they study most
Cardiovascular Risk, Chronic Kidney Disease, Heart Failure, Inflammation, Obesity, Overweight, Type 2 Diabetes Mellitus
Studies at this site
- ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
- A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor — Completed
- A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
- Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed